| Size & multiples | |||
| Market Cap | — | Enterprise Value | — |
| P/E (TTM) | — | PEG (trailing) | — |
| P/S | — | P/FCF | — |
| EV/EBITDA | — | EV/EBIT | — |
| EV/Sales | — | EV/FCF | — |
| FCF Yield | — | Buyback Yield | — |
| Owner Earnings Yield | — | Shareholder Yield | — |
| Cost of capital & EVAmethodology → | |||
| Beta (5y monthly) | 0.36 | Risk-free (assumed) | 4.00% |
| Equity risk premium (assumed) | 5.00% | Cost of Equity | 5.82% |
| After-tax Cost of Debt | — | WACC | — |
| ROIC | — | EVA Spread (ROIC−WACC) | — |
| EVA | — | ||
Flows latest annual · EPS TTM $19.57 · revenue TTM $4.25B · FCF TTM $679.0M
Output of a disclosed model whose assumptions may be wrong — research information, not investment advice. See the Disclaimer.
Compared against all 1054 Health Care names we cover — one sector-wide pool, so the median skews toward smaller (often unprofitable) companies. Try the Size band for a cap-matched read.
| Metric | This (FY) | Peer median | IQR (25–75) | %ile |
|---|---|---|---|---|
| Net Margin | 30.4% | -21.2% | -325.3%–7.2% | 94 ↑strong |
| Operating Margin | 24.8% | -34.5% | -552.0%–8.0% | 93 ↑strong |
| ROE | 20.2% | -36.8% | -92.5%–4.5% | 90 ↑strong |
